Rhythm Pharmaceuticals, Inc. (RYTM)
107.17
-5.36
(-4.76%)
USD |
NASDAQ |
Aug 28, 16:00
107.27
+0.10
(+0.09%)
After-Hours: 20:00
Rhythm Pharmaceuticals Cash from Investing (Quarterly) : 14.01M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.01M |
| March 31, 2026 | 57.05M |
| December 31, 2025 | 30.35M |
| September 30, 2025 | -246.35M |
| June 30, 2025 | 54.04M |
| March 31, 2025 | 24.81M |
| December 31, 2024 | 21.16M |
| September 30, 2024 | -90.82M |
| June 30, 2024 | -8.562M |
| March 31, 2024 | 30.05M |
| December 31, 2023 | 22.64M |
| September 30, 2023 | -94.96M |
| June 30, 2023 | 48.19M |
| March 31, 2023 | 18.46M |
| December 31, 2022 | -40.78M |
| September 30, 2022 | -39.70M |
| June 30, 2022 | 35.98M |
| March 31, 2022 | 72.52M |
| December 31, 2021 | 7.248M |
| September 30, 2021 | 62.78M |
| June 30, 2021 | 13.52M |
| March 31, 2021 | -145.71M |
| Date | Value |
|---|---|
| December 31, 2020 | 61.89M |
| September 30, 2020 | 34.91M |
| June 30, 2020 | 32.86M |
| March 31, 2020 | 28.87M |
| December 31, 2019 | -139.13M |
| September 30, 2019 | 41.47M |
| June 30, 2019 | 46.14M |
| March 31, 2019 | 23.54M |
| December 31, 2018 | 12.28M |
| September 30, 2018 | -136.47M |
| June 30, 2018 | 16.44M |
| March 31, 2018 | 20.61M |
| December 31, 2017 | -111.45M |
| September 30, 2017 | 6.443M |
| June 30, 2017 | 2.983M |
| March 31, 2017 | -8.019M |
| December 31, 2016 | |
| September 30, 2016 | 1.072M |
| June 30, 2016 | -3.945M |
| March 31, 2016 | -2.341M |
| December 31, 2015 | -0.017M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| BioMarin Pharmaceutical, Inc. | -5.102B |
| Cytokinetics, Inc. | -507.00M |
| Exelixis, Inc. | 91.43M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.152M |
| Cash from Financing (Quarterly) | -1.165M |
| Free Cash Flow | -146.30M |
| Free Cash Flow Per Share (Quarterly) | -0.1334 |
| Free Cash Flow to Equity (Quarterly) | 108.08M |
| Free Cash Flow to Firm (Quarterly) | -4.571M |
| Free Cash Flow Yield | -2.02% |